Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Bayer Wins Specialty CV Deal

Feb 01 2006

Related Content

The Anti-Global, Specialist Strategy: Why Bayer's Choice Might Be Right for Other Pharmas

Jan 01 2005

Anatomy of a Deal: Inside the AstraZeneca/ AtheroGenics Agreement

Feb 01 2006

AstraZeneca Joins the In-Licensing Game

Feb 01 2006

Related Companies

Nuvelo

Bayer AG

AstraZeneca PLC

AtheroGenics, Inc.

Schering-Plough

Amgen, Inc.

Johnson & Johnson

Johnson & Johnson

Boehringer Ingelheim GmbH

Sanofi

GSK plc

Solvay SA

Portola Pharmaceuticals, Inc.

Additional Topics

Strategy Business Strategies BioPharmaceutical

More from Business Strategy

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window